- Market Capitalization, $K 368,796
- Shares Outstanding, K 226,255
- Annual Sales, $ 1,440 K
- Annual Income, $ -78,760 K
- 60-Month Beta -1.69
- Price/Sales 248.25
- Price/Cash Flow N/A
- Price/Book 9.02
|Period||Period Low||Period High||Performance|
| || |
+0.0800 (+5.44%)since 07/02/21
| || |
-0.1200 (-7.19%)since 04/30/21
| || |
-1.0100 (-39.45%)since 07/31/20
Athersys, Inc. (Nasdaq: ATHX) will release its second quarter 2021 financial results at approximately 4:00 PM Eastern Time on Monday, August 9, 2021, and will host a conference call shortly thereafter...
Reportlinker.com announces the release of the report "Soft Tissue Repair Global Market Report 2021: COVID-19 Growth And Change" - https://www.reportlinker.com/p06103738/?utm_source=GNW
Athersys, Inc. (NASDAQ: ATHX) announced today that data accumulated from several years of preclinical research was published in the peer-reviewed journal Scientific Reports. The publication describes the...
Ivor Macleod, Chief Financial Officer of Athersys Inc. (NASDAQ: ATHX), is scheduled to speak at the Bank of America Securities 2021 Virtual Health Care Conference on Wednesday, May 12, 2021 at 12:30 pm...
Athersys, Inc. (ATHX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Athersys, Inc. (Nasdaq: ATHX) will release its first quarter 2021 financial results at approximately 4:00 PM Eastern Time on Thursday, May 6, 2021, and will host a conference call shortly thereafter at...
Athersys, Inc. (NASDAQ: ATHX) announced today that Mr. Ivor Macleod, Chief Financial Officer, will present a corporate overview at the 20th Annual Needham Virtual Healthcare Conference. The presentation...
Athersys, Inc. (Nasdaq: ATHX) announced today that its partner HEALIOS K.K. (Healios) has completed enrollment in the ONE-BRIDGE study in Japan evaluating MultiStem(R) (invimestrocel) in patients with...
Athersys, Inc. (NASDAQ: ATHX) announced today its fourth quarter 2020 and annual 2020 financial results and recent highlights.
, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for LPCN, ATHX, NCLH, NBEV, and GME.
|Etfmg Treatments Testing and Advancements ETF|
|Micro-Cap Ishares ETF|
|Ishares Factors US Small Blend Style ETF|
|US Innovative Healthcare Ishares Evolved ETF|
|Russell 2000 Growth Ishares ETF|
|3rd Resistance Point||1.7267|
|2nd Resistance Point||1.6833|
|1st Resistance Point||1.6567|
|1st Support Level||1.5867|
|2nd Support Level||1.5433|
|3rd Support Level||1.5167|